MRD response in a refractory paediatric T-ALL patient through anti-programmed cell death 1 (PD-1) Ab treatment associated with induction of fatal GvHD

被引：16

作者：

Boekstegers, A-M ^{[1
]}

Blaeschke, F. ^{[1
]}

Schmid, I. ^{[1
]}

Wiebking, V. ^{[1
]}

Immler, S. ^{[1
]}

Hoffmann, F. ^{[1
]}

Bochmann, K. ^{[2
]}

Mueller, S. ^{[3
]}

Gruenewald, T. G. P. ^{[4
]}

Feucht, J. ^{[5
]}

Feuchtinger, T. ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Childrens Hosp, Dr von Hauner Univ, Dept Paediat Hematol Oncol & Stem Cell Transplant, Munich, Germany

[2] Ludwig Maximilians Univ Munchen, Dept Clin Radiol, Inst Clin Radiol, Munich, Germany

[3] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany

[4] Ludwig Maximilians Univ Munchen, Max Eder Res Grp Pediat Sarcoma Biol, Inst Pathol, Munich, Germany

[5] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA

来源：

BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 08期

关键词：

ACUTE LYMPHOBLASTIC-LEUKEMIA; RELAPSE; TRANSPLANTATION; MALIGNANCIES; IPILIMUMAB; LYMPHOMA; BLOCKADE;

D O I：

10.1038/bmt.2017.107

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1221 / 1224

页数：4

共 12 条

[1] Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation [J].

Angenendt, L. ;

Schliemann, C. ;

Lutz, M. ;

Rebber, E. ;

Schulze, A. B. ;

Weckesser, M. ;

Stegger, L. ;

Schaefers, M. ;

Groth, C. ;

Kessler, T. ;

Lenz, G. ;

Stelljes, M. ;

Berdel, W. E. .

BONE MARROW TRANSPLANTATION, 2016, 51 (03) :443-445

[2] CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation [J].

Bashey, Asad ;

Medina, Bridget ;

Corringham, Sue ;

Pasek, Mildred ;

Carrier, Ewa ;

Vrooman, Linda ;

Lowy, Israel ;

Solomon, Scott R. ;

Morris, Lawrence E. ;

Holland, H. Kent ;

Mason, James R. ;

Alyea, Edwin P. ;

Soiffer, Robert J. ;

Ball, Edward D. .

BLOOD, 2009, 113 (07) :1581-1588

[3] Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies [J].

Berger, Raanan ;

Rotem-Yehudar, Rinat ;

Slama, Gideon ;

Landes, Shimon ;

Kneller, Abraham ;

Leiba, Merav ;

Koren-Michowitz, Maya ;

Shimoni, Avichai ;

Nagler, Arnon .

CLINICAL CANCER RESEARCH, 2008, 14 (10) :3044-3051

[4] Ipilimumab for Patients with Relapse after Allogeneic Transplantation [J].

Davids, Matthew S. ;

Kim, Haesook T. ;

Bachireddy, Pavan ;

Costello, Caitlin ;

Liguori, Rebecca ;

Savell, Alexandra ;

Lukez, Alexander P. ;

Avigan, David ;

Chen, Yi-Bin ;

McSweeney, Peter ;

LeBoeuf, Nicole R. ;

Rooney, Michael S. ;

Bowden, Michaela ;

Zhou, Chensheng W. ;

Granter, Scott R. ;

Hornick, Jason L. ;

Rodig, Scott J. ;

Hirakawa, Masahiro ;

Severgnini, Mariano ;

Hodi, F. Stephen ;

Wu, Catherine J. ;

Ho, Vincent T. ;

Cutler, Corey ;

Koreth, John ;

Alyea, Edwin P. ;

Antin, Joseph H. ;

Armand, Philippe ;

Streicher, Howard ;

Ball, Edward D. ;

Ritz, Jerome ;

Bashey, Asad ;

Soiffer, Robert J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (02) :143-153

[5] Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97 [J].

Escherich, G. ;

Horstmann, M. A. ;

Zimmermann, M. ;

Janka-Schaub, G. E. .

LEUKEMIA, 2010, 24 (02) :298-308

[6] T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts [J].

Feucht, Judith ;

Kayser, Simone ;

Gorodezki, David ;

Hamieh, Mohamad ;

Doring, Michaela ;

Blaeschke, Franziska ;

Schlegel, Patrick ;

Bosmuller, Hans ;

Quintanilla-Fend, Leticia ;

Ebinger, Martin ;

Lang, Peter ;

Handgretinger, Rupert ;

Feuchtinger, Tobias .

ONCOTARGET, 2016, 7 (47) :76902-76919

[7] Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia [J].

Goulden, N ;

Bader, P ;

Van der Velden, V ;

Moppett, J ;

Schilham, M ;

Masden, HO ;

Krejci, O ;

Kreyenberg, H ;

Lankester, A ;

Révész, T ;

Klingebiel, T ;

Van Dongen, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) :24-29

[8] Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia [J].

Schrappe, Martin ;

Hunger, Stephen P. ;

Pui, Ching-Hon ;

Saha, Vaskar ;

Gaynon, Paul S. ;

Baruchel, Andre ;

Conter, Valentino ;

Otten, Jacques ;

Ohara, Akira ;

Versluys, Anne Birgitta ;

Escherich, Gabriele ;

Heyman, Mats ;

Silverman, Lewis B. ;

Horibe, Keizo ;

Mann, Georg ;

Camitta, Bruce M. ;

Harbott, Jochen ;

Riehm, Hansjoerg ;

Richards, Sue ;

Devidas, Meenakshi ;

Zimmermann, Martin .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15) :1371-1381

[9] Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study [J].

Schrappe, Martin ;

Valsecchi, Maria Grazia ;

Bartram, Claus R. ;

Schrauder, Andre ;

Panzer-Gruemayer, Renate ;

Moericke, Anja ;

Parasole, Rosanna ;

Zimmermann, Martin ;

Dworzak, Michael ;

Buldini, Barbara ;

Reiter, Alfred ;

Basso, Giuseppe ;

Klingebiel, Thomas ;

Messina, Chiara ;

Ratei, Richard ;

Cazzaniga, Giovanni ;

Koehler, Rolf ;

Locatelli, Franco ;

Schaefer, Beat W. ;

Arico, Maurizio ;

Welte, Karl ;

van Dongen, Jacques J. M. ;

Gadner, Helmut ;

Biondi, Andrea ;

Conter, Valentino .

BLOOD, 2011, 118 (08) :2077-2084

[10] Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin's lymphoma [J].

Singh, A. K. ;

Porrata, L. F. ;

Aljitawi, O. ;

Lin, T. ;

Shune, L. ;

Ganguly, S. ;

McGuirk, J. P. ;

Abhyankar, S. .

BONE MARROW TRANSPLANTATION, 2016, 51 (09) :1268-1270

← 1 2 →